342 related articles for article (PubMed ID: 30719075)
21. ELK3 promotes the migration and invasion of liver cancer stem cells by targeting HIF-1α.
Lee JH; Hur W; Hong SW; Kim JH; Kim SM; Lee EB; Yoon SK
Oncol Rep; 2017 Feb; 37(2):813-822. PubMed ID: 27959451
[TBL] [Abstract][Full Text] [Related]
22. The Progress and Prospects of Putative Biomarkers for Liver Cancer Stem Cells in Hepatocellular Carcinoma.
Xiang Y; Yang T; Pang BY; Zhu Y; Liu YN
Stem Cells Int; 2016; 2016():7614971. PubMed ID: 27610139
[TBL] [Abstract][Full Text] [Related]
23. Alanine-Glyoxylate Aminotransferase Sustains Cancer Stemness Properties through the Upregulation of SOX2 and OCT4 in Hepatocellular Carcinoma Cells.
Ye P; Chi X; Yan X; Wu F; Liang Z; Yang WH
Biomolecules; 2022 May; 12(5):. PubMed ID: 35625596
[TBL] [Abstract][Full Text] [Related]
24. A novel oncolytic adenovirus targeting Wnt signaling effectively inhibits cancer-stem like cell growth via metastasis, apoptosis and autophagy in HCC models.
Zhang J; Lai W; Li Q; Yu Y; Jin J; Guo W; Zhou X; Liu X; Wang Y
Biochem Biophys Res Commun; 2017 Sep; 491(2):469-477. PubMed ID: 28698142
[TBL] [Abstract][Full Text] [Related]
25. Regulators of liver cancer stem cells.
Liu K; Ou JJ
World J Stem Cells; 2021 Aug; 13(8):1127-1133. PubMed ID: 34567430
[TBL] [Abstract][Full Text] [Related]
26. FEN1 upregulation mediated by SUMO2 via antagonizing proteasomal degradation promotes hepatocellular carcinoma stemness.
Peng Z; Wang S; Wen D; Mei Z; Zhang H; Liao S; Lv L; Li C
Transl Oncol; 2024 Jun; 44():101916. PubMed ID: 38513457
[TBL] [Abstract][Full Text] [Related]
27. MK2206 overcomes the resistance of human liver cancer stem cells to sorafenib by inhibition of pAkt and upregulation of pERK.
Zhai B; Zhang X; Sun B; Cao L; Zhao L; Li J; Ge N; Chen L; Qian H; Yin Z
Tumour Biol; 2016 Jun; 37(6):8047-55. PubMed ID: 26711788
[TBL] [Abstract][Full Text] [Related]
28. Tg737 acts as a key driver of invasion and migration in liver cancer stem cells and correlates with poor prognosis in patients with hepatocellular carcinoma.
You N; Tan Y; Zhou L; Huang X; Wang W; Wang L; Wu K; Mi N; Li J; Zheng L
Exp Cell Res; 2017 Sep; 358(2):217-226. PubMed ID: 28663060
[TBL] [Abstract][Full Text] [Related]
29. [Molecular markers and mechanisms for stemness maintenance of liver cancer stem cells: a review].
Zhang N; Bai S; Zhang F; Shi M; Wang L; Wang L; Xu L; Yang Z; Yu C
Sheng Wu Gong Cheng Xue Bao; 2021 Aug; 37(8):2719-2736. PubMed ID: 34472291
[TBL] [Abstract][Full Text] [Related]
30. High expression of MAGE-A9 contributes to stemness and malignancy of human hepatocellular carcinoma.
Wei Y; Wang Y; Gong J; Rao L; Wu Z; Nie T; Shi D; Zhang L
Int J Oncol; 2018 Jan; 52(1):219-230. PubMed ID: 29138811
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-1305 Inhibits the Stemness of LCSCs and Tumorigenesis by Repressing the UBE2T-Dependent Akt-Signaling Pathway.
Wei X; You X; Zhang J; Zhou C
Mol Ther Nucleic Acids; 2019 Jun; 16():721-732. PubMed ID: 31128423
[TBL] [Abstract][Full Text] [Related]
32. Systems approach to characterize the metabolism of liver cancer stem cells expressing CD133.
Hur W; Ryu JY; Kim HU; Hong SW; Lee EB; Lee SY; Yoon SK
Sci Rep; 2017 Apr; 7():45557. PubMed ID: 28367990
[TBL] [Abstract][Full Text] [Related]
33. 8-bromo-5-hydroxy-7-methoxychrysin targeting for inhibition of the properties of liver cancer stem cells by modulation of Twist signaling.
Ren KQ; Cao XZ; Liu ZH; Guo H; Quan MF; Liu F; Jiang L; Xiang HL; Deng XY; Cao JG
Int J Oncol; 2013 Nov; 43(5):1719-29. PubMed ID: 23970349
[TBL] [Abstract][Full Text] [Related]
34. CCND1 silencing suppresses liver cancer stem cell differentiation through inhibiting autophagy.
Zhang H
Hum Cell; 2020 Jan; 33(1):140-147. PubMed ID: 31667787
[TBL] [Abstract][Full Text] [Related]
35. iNOS promotes CD24
Wang R; Li Y; Tsung A; Huang H; Du Q; Yang M; Deng M; Xiong S; Wang X; Zhang L; Geller DA; Cheng B; Billiar TR
Proc Natl Acad Sci U S A; 2018 Oct; 115(43):E10127-E10136. PubMed ID: 30297396
[TBL] [Abstract][Full Text] [Related]
36. Effective elimination of liver cancer stem-like cells by CD90 antibody targeted thermosensitive magnetoliposomes.
Yang R; An LY; Miao QF; Li FM; Han Y; Wang HX; Liu DP; Chen R; Tang SQ
Oncotarget; 2016 Jun; 7(24):35894-35916. PubMed ID: 27145285
[TBL] [Abstract][Full Text] [Related]
37. The Underlying Mechanisms of Noncoding RNAs in the Chemoresistance of Hepatocellular Carcinoma.
Wang M; Yu F; Chen X; Li P; Wang K
Mol Ther Nucleic Acids; 2020 Sep; 21():13-27. PubMed ID: 32505000
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of miR-200a suppresses epithelial-mesenchymal transition of liver cancer stem cells.
Wang J; Yang X; Ruan B; Dai B; Gao Y; Duan J; Qu S; Tao K; Dou K; Li H
Tumour Biol; 2015 Apr; 36(4):2447-56. PubMed ID: 25412960
[TBL] [Abstract][Full Text] [Related]
39. CD133 silencing inhibits stemness properties and enhances chemoradiosensitivity in CD133-positive liver cancer stem cells.
Lan X; Wu YZ; Wang Y; Wu FR; Zang CB; Tang C; Cao S; Li SL
Int J Mol Med; 2013 Feb; 31(2):315-24. PubMed ID: 23233126
[TBL] [Abstract][Full Text] [Related]
40. Ultrasound-targeted microbubble destruction-mediated downregulation of CD133 inhibits epithelial-mesenchymal transition, stemness and migratory ability of liver cancer stem cells.
Liu YM; Li XF; Liu H; Wu XL
Oncol Rep; 2015 Dec; 34(6):2977-86. PubMed ID: 26370320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
